Market Research Blog

The Global superficial radiation therapy system market is set to record a market value of U.S$ 43.3 Mn in the year 2022 with a CAGR of 3.8% which indicates a positive market growth over the forecast period. The global coronavirus outbreak is anticipated to have a moderate impact on the industry throughout the pandemic crisis. While the essential nature of basal and squamous cell cancer treatments will support demand. Strict procedures to screen covid-19 patients prior to superficial radiation therapy treatments holds back application rates during this period.

“Growing efforts for the testing and approval of superficial radiation therapy by government bodies are key factors contributing to growth prospects. Further, growing consumer bias against invasive treatment options and research investments for oncology will help long-term growth of the industry,” says the FMI study.

Superficial Radiation Therapy System Market – Key Takeaways

• Basal cell carcinoma applications account for significant revenue share, owing to high incidence rates particularly among fair-skinned populations.
• Targeted therapy systems are witnessing major growth, supported by minimal risks of side effects.
• North America is a prominent market for superficial radiation therapy systems, owing to higher numbers of treatment centers, and clinical trials in the region.

Superficial Radiation Therapy System Market – Key Driving Factors

• Major investments towards the development of non-invasive skin cancer treatments, and portable devices are key to market developments.
• Rising numbers of awareness programs run by governments on skin cancer and treatment options are bolstering growth prospects.

Superficial Radiation Therapy System Market – Key Constraints

• Debate about the efficacy of superficial radiation therapy in healthcare circles is holding back adoption.
• Prohibitive costs of operating superficial radiation therapy systems restrict market growth.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-5279

The Anticipated Impact of Coronavirus

The superficial radiation therapy systems market has been moderately limited in applications during the coronavirus pandemic. Lockdown restrictions and social distancing guidelines have resulted in delayed appointments for superficial radiation therapy treatments. Disinfection requirements and strict screening for covid-19 cases, restricts access to patients and hurts operation rates limiting demand for superficial radiation therapy systems in the short term. Recovery is highly dependent on the timeline to bring the pandemic under control.

Competition Landscape

Major manufacturers in the superficial radiation therapy system market include but are not limited to Nordion Inc., Sensus Healthcare, Xstrahl Ltd., SkinCure, IsoRay Inc., Mevion Medical Systems, Mitsubishi Electric Corp., Varian Medical Systems, Electa AB, Ion Beam Applications, and RaySearch Laboratories.

Superficial radiation therapy system manufacturers have been investing in strategic collaborations and acquisitions for product innovation and manufacturing capability enhancements.

For instance, Sensus Healthcare has announced the acquisition of Aesthetic Laser Partners and Aesthetic Mobile Laser Services for dermatology capabilities including superficial radiation therapy systems. IntraOp Medical Corp. has entered into a partnership with the Lausanne University Hospital for clinical trials of FLASH radiotherapy which includes superficial radiation therapy functionality. Also, Stratpharma Inc. has joined hands with Sensus Healthcare for development of topical medical products including superficial radiation therapy systems.

More About the Report

The FMI’s market research report offers detailed insights on superficial radiation therapy system market. The market is scrutinized on the basis of product type (systems and software), application (basal cell carcinoma, squamous cell carcinoma, keloid scars, psoriasis, Kaposi sarcoma, Bowen’s disease, cutaneous T-cell lymphoma, and soft tissue metastases), and end user (hospitals, ambulatory surgical center, cancer research institutes, and dermatology centers), across seven key regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East and Africa).

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-5279

Superficial Radiation Therapy System Market By Category

By Product Type :

• Superficial Radiation Therapy Systems
• Software

By Application :

• Basal Cell Carcinoma
• Squamous Cell Carcinoma
• Keloid scars
• Psoriasis
• Kaposi Sarcoma (Plaque Stage)
• Bowen’s Disease
• Cutaneous T-cell Lymphoma
• Soft Tissue Metastases

By End User :

• Hospitals
• Ambulatory Surgical Centers
• Cancer Research Institutes
• Dermatology Centers

By Region :

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle-East & Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-5279

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global medical hyperspectral imaging market will reach nearly USD 300 million by 2030, according to a new market research study by Future Market Insights (FMI), an ESOMAR-certified firm.

Growing number of healthcare ailments continues to drive advancements in medical imaging landscape. As such, computational power, image analysis, and hyperspectral cameras are the technological innovations being implemented all across the healthcare industry.

Non-invasive diseases as well as surgeries are being precisely figured out by imaging sensors. Also, they do not emit any sort of radiation to harm the patient or operator. According to FMI’s analysis, these factors will provide impetus to the market during the assessment period.

 “Proven success in North America and Europe is prompting medical hyperspectral imaging market players to shift their priorities to the developing economies. This factor will help in growth of the market between 2020 and 2030” – FMI Analyst

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12369

Key Takeaways

• Hyperspectral camera holds the largest market share owing to latest advancements with respect to sensor development
• High preference for accuracy to boost prospects of MHSI in healthcare
• US and Europe to collectively account for nearly 40% revenue share
• India’s growth as a medical tourism hub to create opportunities for market players

Although FMI’s report is bullish on the use of hyperspectral imaging in medical applications, initial investments and reluctance to experiment will lead to limited adoption, especially in the next couple of years.

FMI’s discussion with stakeholders across the value chain revealed that concerns related to data storage, and the subsequent associated cost has been a key restraint for end-users. Many providers are offering cloud-based storage options, and it is likely that over the course of the forecast period, adoption will gradually increase.

Hyperspectral imaging used in a range of sectors apart from healthcare. The key hyperspectral imaging players are continuously focusing on offering technologically-superior products, not just for the healthcare industry.

According to FMI, holistic advances in hyperspectral imaging will boost the confidence of healthcare industry and fuel adoption. However, manufacturers will need to maintain that elusive balance between quality offerings and competitive pricing.

List of Key Players Covered in Medical Hyperspectral Imaging market are:

• IMEC
• Norsk Elektro Optikk
• Galileo
• Gilden Photonics
• Resonon
• XIMEA
• Gooch & Housego
• Chemlmage
• Applied Spectral Imaging
• Cubert
• EVK DI Kerschhaggl
• Headwall Photonics
• FluxData

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-12369

Key Segments of Medical Hyperspectral Imaging Industry Survey

Medical Hyperspectral Imaging Market by Product:

• Hyperspectral Imaging Systems
• Hyperspectral Imaging Accessories

Medical Hyperspectral Imaging Market by Application:

• Medical Diagnosis
• Tissue and Cell Biology
• Drug Discovery
• Others

Medical Hyperspectral Imaging Market by Technology:

• Visible Hyperspectral Imaging
• Near-infrared Hyperspectral Imaging
• Ultraviolet Hyperspectral Imaging
• Short-wave Infrared Imaging
• Mid-wave Infrared Hyperspectral Imaging

Medical Hyperspectral Imaging Market by End User:

• Diagnostic Centres
• Hospitals
• Research & Academic Centres
• Pharmaceutical & Biotechnology Companies

Medical Hyperspectral Imaging Market by Region:

• North America Medical Hyperspectral Imaging Market
• Latin America Medical Hyperspectral Imaging Market
• Europe Medical Hyperspectral Imaging Market
• East Asia Medical Hyperspectral Imaging Market
• South Asia & Pacific Medical Hyperspectral Imaging Market
• Middle East & Africa (MEA) Medical Hyperspectral Imaging Market

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-12369

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global ankylosing spondylitis treatment market will continue to witness steady growth, driven by a slew of myriad, yet interconnected factors. A new report by ESOMAR-certified market research firm, Future Market Insights, offers incisive insights on key factors that will influence growth through 2030.

According to FMI’s report, the options for treatment include disease-modifying anti-rheumatic drugs (methotrexate), nonsteroidal anti-inflammatory drugs (naproxen, ibuprofen, celecoxib, meloxicam, and diclofenac), biologics (certolizumab pegol, secukinumab, infliximab), and biosimilars.

Key Takeaways from Ankylosing Spondylitis Treatment Market Study

• Nonsteroidal anti-inflammatory drugs lead the market as they are looked upon as the first line of treatment for ankylosing spondylitis
• Oral route of administration holds the largest market share due to simplicity of consumption.
• By age group, “adults” contribute to majority of revenue generation as ankylosing spondylitis usually gets initiated in adulthood.
• North America, led by the US, holds the highest market share due to well-established healthcare infrastructure, high incidences of ankylosing spondylitis, and innovations in pharmaceutical industry.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-12345

Ankylosing Spondylitis Treatment Market Landscape

The major players in the ankylosing spondylitis market include Wyeth, Mitsubishi Tanabe, Schering-Plough, Takeda, Novartis AG, Amgen, Centocor, Abbott, Eisai, and Pfizer.

As per the Oxford University Press, around 1% of the US population, 1.3-1.56 Mn European population, and 4.63-4.98 Mn population in the Asia Pacific are affected by ankylosing spondylitis. Also, the market is witnessing massive investment on the part of research to table new formulations.

Inorganic growth parameters are also contributing a great deal to the growth of ankylosing spondylitis treatment market. For instance – Novartis AG, in Jan 2019, entered into a collaboration with TrialSpark with an objective of increasing patients’ access to the clinical trials. The enrollment timeline is expected to shorten, thereby speeding up development of novel therapies.

In Oct 2019, the European Commission approved Cosentyx to treat non-radiographic axial spondyloarthritis. The next step includes submission of label update application to US FDA and post approval, the market is expected to grow substantially.

“Agreement” is the other strategy used. For instance – Izana Bioscience, in Dec 2017, entered into a global license agreement with Takeda Pharmaceutical Company for manufacturing, commercializing, and developing Namilumab to treat ankylosing spondylitis.

Also, Zydus Cadila, in Nov 2017, launched Adalimumab’s biosimilar in India. It has been used to treat ankylosing spondylitis, rheumatoid arthritis, juvenile idiopathic arthritis.

Initiatives like these have been giving impetus to the ankylosing spondylitis market and the status quo is likely to remain the same in the forecast period.

Want More Insights?

The global ankylosing spondylitis treatment market is elaborated on the basis of drug class (Nonsteroidal Anti-inflammatory Drugs, Anti-Inflammatory Drugs, Immunosuppressive Drugs, TNF Blockers, JAK Inhibitors, Steroids, Biologics, and Others), route of administration (parenteral, oral), application (Adults, juvenile), and geography (North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA).

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-12345

Key Segment

Drug Class

• Nonsteroidal Anti-inflammatory Drugs
• Anti-Inflammatory Drugs
• Immunosuppressive Drugs
• TNF Blockers
• JAK Inhibitors
• Steroids
• Biologics
• Others

Route of Administration

• Parenteral
• Oral

Application

• Adults
• Juveniles

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-12345

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market reached US$ 3.57 Bn in 2022 (up by 4.7% over 2021). Outbreak of Covid-19 in the short-term, backed by “innovation” in the long run, is expected to drive the market.

Sepsis, toxic shock syndrome, bacteremia, osteomyelitis, endocarditis, meningitis, pneumonia are amongst the life-threatening diseases caused by Staphylococcus Aureus bacteria. These diseases are cured by antibiotics.

Some form of staphylococcus aureus that has developed resistance to a broad range of antibiotics fall in the category of “Methicillin-Resistant Staphylococcus Aureus (MRSA)”. This resistance is one of the key factors driving the market in the near future as well as extensive research ought to be on the anvil to devise new medications.

According to FMI’s latest study, the rising incidences of MRSA all over the world are likely to create demand for safe and efficient drugs during the forecast period.

Covid-19 Pandemic: A Short-term Upholsterer

Outbreak of novel corona virus has resulted in short-term considerable increase in the number of MRSA infections. This number is expected to boost the market demand for MRSA antibiotics during the ongoing Covid-19 crisis. As per the latest data, around 2.5 million people have been infected by Covid-19 so far.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-10406

Key Takeaways of MRSA Treatment Market Study 

• In terms of drug class, glycopeptides (vancomycin) and oxazolidinones (linezolid) are collectively expected to account for over 75% of revenue share in the MRSA treatment market owing to preference of both antibiotic classes as a first-line treatment against MRSA infections and used in more than 80% of MRSA cases treatment.
• By route of administration, intravenous (IV) route of administration remains the recommended option. Drugs that can be administered through IV are likely to gain more than one-half of market share in the MRSA treatment market during the forecast period.
• By indication, skin and soft tissue infections (SSTIs) are leading the market and expected to gain more than 40% of revenue share followed by the pneumonia over the forecast period.
• Incidence of healthcare acquired MRSA is higher than community acquired MRSA, and FMI opines status-quo to remain unchanged during the assessment period
• North America is the highest revenue generating market by region due to high incidence of MRSA infections
• Asia Pacific is expected to witness high demand for MRSA testing systems due to high incidences of MRSA infection herein. For example – Journal of Family Medicine and Primary Care, in 2021, stated that occurrence of MRSA among kids aged 5 to 15 is between 16 and 52%. India alone accounts for 4-19% of these infections.

Government and Pharma Industry Focus on Working in Unison to Develop Advanced Treate  

As per University of Melbourne’s researchers, “Teixobactin” responds positively against MRSA. These results are likely to pave the way for development of antibacterial drugs to treat multi-drug resistant Gram-positive infections with thick cell wall. This will open wider doors for MRSA treatment market all over Australia and the other countries in Asia-Pacific. Teixobactin is already known for destroying Mycobacterium tuberculosis.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-10406

Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market By Category

By Drug Class :

By Indication :

• Skin and Soft Tissue Infections (SSTIs)
• Pneumonia
• Bloodstream Infections
• Surgical and Medical Infections
• Others

By Route of Administration :

• Intravenous
• Oral
• Topical
• Nasal
• Cutaneous
• Intramuscular

By Type of MSRA :

• Healthcare Acquired MRSA
• Community Acquired MRSA
• Hospital Acquired MRSA

By Distribution Channel :

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

By Region :

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-10406

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Global injectable benzodiazepine sales are set to reach USD 260 million in 2020, as covid-19 panic and uncertainty has set in, even among population with no previous history of mental illnesses, according to a new study by Future Market Insights (FMI). The market research firm estimates the market to grow at 2.7% CAGR through 2030.

The global tip location devices market is likely to surpass USD 35 million in revenues by 2020-end, according to a latest report by Future Market Insights (FMI). The ESOMAR-certified firm has an optimistic outlook on the long-term prospects of tip location devices market, with its latest report forecasting a 6.4% CAGR through 2030.

Tip location devices are being commercialized as a solution to incorrect positioning of catheters. Using tip locator devices does reduce incidences of this incorrect positioning by 10-16% as they make use of micro sensors to gauge the catheter’s position. This, in turn, reduces the cost of catheterization as the conventional technique of X-Rays is not employed over here. This precision followed by cost-effectiveness are likely to drive the tip location devices market in the forecast period.

Moreover, the players have been an active part of global conferences with respect to showcasing the product portfolio. These measures are expected to increase the visibility of the players as a brand.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-880

For instance – Teleflex Incorporated, in Sep 2019, participated at the conference conducted by Cardiovascular and Interventional Radiological Society of Europe by presenting its Peripheral Intervention Product Portfolio. The conference was held in Barcelona.

Key Takeaways from Tip Location Devices Marker Study

• Tip location system anticipated to witness a CAGR of 5% between 2020 and 2030
• ECG with magnetic tracking accounted for more than 60% of market share in terms of revenue in 2019.
• North America to account for more than 50% of market share in 2020 and the trend is expected to continue in the forecast period.

Competitive Intelligence

The global market is set to widen its scope in the forecast period, stimulated by rising number PICC procedures globally and adoption of tip confirmatory systems for during catheter insertion. The key market players covered by FMI include C.R. Bard, Inc., Teleflex Incorporated, AngioDynamics Inc., Vygon S.A., CORPAK MedSystems. Coming up with easy-to-use and advanced tip location devices is one of the objectives of these players.

For instance – Teleflex’s “Arrow VPS Rhythm Device with TipTracker Technology” does need any calibration, expedites patient therapy (with elimination of X-Ray or Fluoroscopy), and simplifies PICC insertion.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-880

On the similar lines, AngioDynamics has tabled next generation of Peripheral Atherectomy Technology. Acquiring Auryon has facilitated this state-of-the art technology.

CORTRAK* 2 ENTERAL ACCESS SYSTEM (EAS) is an electromagnetic stylet from Avanos that gives real-time location information regarding placement of the tip of the tube. One could get immediate feedback due to on-screen visualization. This eliminates use of X-Ray.

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

The global respiratory pathogen testing kits market was valued at US$2.49 Bn in 2019 up by 5% over 2018. As per study conducted by Future Market Insights (FMI), the market will witness a substantial CAGR of 6.5% between 2020 and 2030. The report states that the prevalence of microbial infections in the form of common cold, pneumonia, tuberculosis, influenza, bronchitis, and the latest – Covid-19 is driving the manufacturers towards increased production of respiratory pathogen testing kits. The global conglomerates are entering into partnership with local players to suffice the increasing demand for these kits.

This report encloses in-depth insights into the respiratory pathogen testing kits market. A few of them are:

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-10542

• The market is estimated to reach US$ 2.65 Bn by the end of 2020.
• Numerous companies are opting for strategic expansion in Asia Pacific due to the ever-increasing incidences of pathogen-centric diseases (more so due to population density in Asia Pacific). Some of them are also tying up with local players to address the increasing demand and provide affordable kits.
• Extensive research being funded by governments/government agencies is contributing to the growth of market and this trend is expected to continue in the forecast period as well.

“Emerging markets such as India, China are in growth phase as the key players in the region are focusing to develop more and new respiratory pathogen testing kits. Latin America and MEA will be following APAC region, entering in the growth phase” says the FMI Analyst.

Outbreak of Covid-19 To Spur the Demand for Respiratory Pathogen Testing Kits

The existing medical conditions impelling the respiratory pathogen testing kits market include bronchitis, pneumonia, TB, influenza, common cold, and tonsillitis. The outbreak of Covid-19 has bolstered the market as the number of cases are rising every single day at an alarming rate. To employ corrective measures within the stipulated timeframe; it’s imperative to have respiratory pathogen testing kits in place. Flagship companies along with government bodies are coming together to keep pace with regards to these kits availability.

On the other hand, certain high-risk professions like coal mines are subject to safety guidelines by their respective governments. These workers, over the period of time, encounter COPD (Chronic Obstructive Pulmonary Disease) as they unknowingly inhale silica dust (abreast with bacteria). The governments mandate regular health check-ups of these workers. As such, these workplaces do make use of respiratory pathogen testing kits for reporting the HQ (health quotient) of the workers. This consistent demand is likely to hold the flag high for respiratory pathogen testing kits market.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-10542

Who Is In Win-Win Situation?

The key respiratory pathogen testing market players covered by FMI include Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Mobidiag, iGenetic Diagnostics, Hoffmann-La Roche Ltd., etc. They are focusing on devising innovative products with competitive pricing, thus expecting to account for maximum market share. The other measures include collaborating with regional market players in the Asia Pacific region in order to expand their clientele and grab respiratory pathogen testing kits market share in emerging economies.

Heavily investing in research to expand product portfolio and market presence globally, especially to cater to the needs of end users, consolidating their positions through mergers, acquisitions, and new product launches is also on the anvil.

Respiratory Pathogen Testing Kits Market: Segmentation

The global respiratory pathogen testing kits market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product

• RT PCR kits
• DFA Kits
• ELISA Kits
• Others

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/10542

By infection/symptoms

• By Matrix
• Enterovirus Infection
• Human Coronavirus Infection
• Influenza  Virus Infection
• Respiratory Syncytial Virus Infection
• Rhinovirus Infection
• Pneumonia
• Others

By Technology

• NAAT (Nucliec Acid Amplification)
• Immunoassay
• Others

End User

• Hospitals
• Diagnostic Centers
• Speciality Clinics

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• MEA

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[201 Pages Report] There has been an increasing demand for medical masks recently, creating an absolute opportunity for growth of the medical mask market.  A new Future Market Insights (FMI) report reveals that the global medical mask market will experience a major upturn post 2022, and further reaching over US$ 9 Bn by the end of 2030.

Medical facility highly depends on medical mask during surgeries. The availability of different versions of mask for different applications across different end-users, such as ambulatory surgical Centre’s, hospitals, dental settings, etc., are expected to fuel the growth of the medical mask market throughout the forecast period.

Get Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11288

Consistent growth in the number of surgeries performed globally is boosting the demand for anesthesia mask and laryngeal masks, which is expected to contribute to the growth of the medical mask market during the forecast period.

Increasing number of infectious diseases and pollution as well as growth in the number of surgeries worldwide are providing further impetus to the growth of medical mask market.

The COVID-19 Impact on Medical Mask Sales

The novel coronavirus (COVID-19) pandemic has put a huge strain on the medical mask market, with the gap between supply and demand gradually widening. COVID-19, being primarily a respiratory disease, makes it imperative to incorporate personal protective equipment (PPE) such as medical masks for both, medical professionals and general public. This is both a challenge and opportunity for market players, which are focusing on scaling up production capacities in order to satiate the rapidly growing demand.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-11288

Key Takeaways of Medical Mask Market Study

• In terms of product type, N95 respirators are expected to contribute over 25% of revenue in the medical mask market.
• Owing to low product cost and demand, surgical mask is the most preferred choice among costumers.
• Surgeries dominate the medical mask market by application, as medical professionals mostly prefer medical masks during surgeries to avoid contamination.
• In terms of end user, hospitals are expected to capture over 50% of share in the medical mask market during the forecast period.
• North America is the highest revenue generating market by region due to well-established and sophisticated healthcare infrastructure. East Asia is expected to offer lucrative opportunities owing to rapid healthcare programs and flourishing medical facilities.

Leading Manufacturers Focus on Mergers & Acquisitions

Leading manufacturers in the medical mask market are focusing on regional mergers & acquisitions to enhance their product portfolio and expand their regional presence.  For instance, in 2021, Examinetics announced its collaboration with Moldex-Metric Inc. to offer online respirator clearance evaluations. In 30 march 2022, the company moved quickly to expand its production capacity for N95 masks and start its new operation in Phoenix.

Want more insights?

Medical mask market, a new study from future market insights, opines on the application of Medical mask from 2014 – 2021 and presents demand projections from 2022 – 2030 on the basis of; product type (surgical mask, N95 respirators, face mask, full-face mask, laryngeal masks and anesthesia masks), application (respiratory safety, infections disease, allergies and surgeries) and end user (hospitals, academic & research institutes, diagnostic laboratories, individual) across seven prominent regions.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-11288

Key Market Segments Covered In Medical Mask Industry Research By Product : 

• Surgical mask
• N95 Respirators
• Face mask
• Full-Face Mask
• Laryngeal Masks
  • Disposable Laryngeal Masks
  • Reusable Laryngeal Masks
• Anaesthesia Masks
  • Disposable Anaesthesia Masks
  • Reusable Anaesthesia Masks

By Application :

• Infections Disease
• Respiratory Safety
• Surgeries
• Allergies
• Others

By End User :

• Hospitals
• Diagnostic Laboratories
• Research and Academic Institutes
• Others

By Region :

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

The global gene synthesis market will expand at an exponential 20% CAGR through 2029. According to a new study by Future Market Insights (FMI), the market for gene synthesis is largely influenced by increasing applications in research institutes, clinical research organizations, and biopharmaceutical companies around the globe, for a variety of products and services.

Request report sample with 250+ pages to gain in-depth insights https://www.futuremarketinsights.com/reports/sample/rep-gb-5924

Key Research Findings 

• On the basis of services, gene services will account for more than 45% of the overall revenue share through the forecast period.
• Standard gene synthesis will remain a preferred variant through the forecast period among consumers driven by low service costs.
• Research and development activities at academic and research institutes, will lead the market in terms of end user applications, accounting for more than 50% of market share.
• Gains of the global gene synthesis market will remain largely concentrated in North America.
• The East Asia Market will display lucrative opportunities, driven by healthcare programs through the forecast period.

Key Growth Drivers 

• Strong activity taking place in the emerging field of synthetic biology plays a major role in the growth of market.
• Widespread use of gene synthesis services for multiple drug development applications to add to the global footprint of players.
• Extensive use of molecular applications for higher service quality and customer loyalty is a major factor contributing to market growth.
• The development of genomic based studies for noble therapeutic applications will drive adoption.

Key Impediments 

• The gene synthesis market is facing increasing challenges owing to price reductions, and tech restraints associated with the highly competitive market landscape.
• Explore the complete gene synthesis market report with 93 illustrative figures, 43 data tables, and the table of contents. Also find a detailed market segmentation on https://www.futuremarketinsights.com/reports/gene-synthesis-market

Competition Structure Analysis – Gene Synthesis Market

The competition landscape of gene synthesis market remains Highly consolidated. Key players are also investing in strengthening service infrastructure, to keep up with the needs of commercialization. Players are also focusing their efforts towards emerging economies including India, Mexico, and Brazil.

Explore Future Market Insights’ detailed coverage on, 

• Home Sleep Screening Devices Market– This research report provides an exhaustive range of insights which identify revenue sectors, essential strategies, and major growth opportunities, associated with home sleep screening devices.
• Amniotic Membrane Market– This report includes a detailed analysis on competitive scenarios, and essential information on major players in the amniotic membrane market.
• Allergy Diagnostics Market– This write up encompasses detailed secondary research, which is used to estimate key industry players, overall size of the allergy diagnostics market, and relevant industry associations.
• Gain access to Market Ngage, an AI-powered, real-time business intelligence platform that goes beyond the conventional research solutions to solve the complex strategy challenges that organizations face today.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[230 Pages Report] Growing prevalence of acute kidney injury as well as increasing early diagnosis with subsequent increasing treatment seeking rate are the prime drivers of the global acute kidney injury treatment market. Treatment such as dialysis therapies has resulted in better management of acute kidney injury, and has helped reduce the risk of various kidney-related diseases.

Various organisations are involved in acute kidney injury disease surveillance. In 2021, China’s central government issued the 13th Five Year National Science and Technology Innovation Plan, which aims to create a national platform to share biomedical big data, develop technologies for precision medicine, and integrate them into a multilevel knowledge database, leading the healthcare treatment market to new growth avenues.

The global acute kidney injury treatment market is projected to exhibit a noteworthy 8% CAGR over the forecast period (2022–2029).

“Increasing prevalence of acute kidney injury across the world and increasing number of dialysis centers are prominent factors augmenting the growth prospects of the global acute kidney injury treatment market.”

Key Takeaways of Acute Kidney Injury Treatment Market Study

• Owing to increasing acute kidney injury prevalence, number of dialysis centers, and efficient treatment method, the dialysis segment is expected to be a significant revenue generator.
• The intermittent hemodialysis segment, under product, in the acute kidney injury treatment market, is expected to be a prominent segment, as results provided by this treatment are more efficient as compared to other dialysis methods.
• The pre-renal injury segment is anticipated to dominate the acute kidney injury treatment market, as pre-renal injury is more prevalent in patients with acute kidney injury.
• North America is expected to dominate the global acute kidney injury treatment market in terms of revenue, owing to the growing adoption of advanced treatments over conventional methods. East Asia is expected to offer lucrative opportunities for the acute kidney injury treatment market during the forecast period.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9399

Advanced Technology & Product Launches – Key Strategies Followed by Manufacturers

Advancements in diagnostic technology and more product availability in order to streamline their product offerings in respective regions with diverse product portfolios are being followed by players in the acute kidney injury treatment market. For instance, in January, 2022, Fresenius Medical Care launched the 4008A dialysis machine to improve accessibility to life-sustaining dialysis treatment.

More Valuable Insights on Acute Kidney Injury Treatment Market

Future Market Insights brings a comprehensive research report on forecast revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each segment from 2014 to 2029. The global acute kidney injury treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the readers.

The study provide compelling insights on the acute kidney injury treatment market on the basis of product (dialysis and drug therapy), injury (pre-renal injury, intrinsic renal injury, and post-renal injury), and distribution channel (hospitals, ambulatory surgical centers, and others), across seven major regions.

Acute Kidney Injury Treatment Market By CategoryProduct : 

• Dialysis
  • Intermittent Hemodialysis
  • Continuous Renal Replacement Therapy (CRRT)
  • Sustained Low Efficiency Dialysis (SLED)
• Drug Therapy
  • Antibiotics
  • Diuretics
  • Immunosuppressive Agents

Injury :

• Pre-renal Injury
• Intrinsic Renal Injury
• Post-renal Injury

Distribution Channel :

• Hospitals
• Ambulatory Surgical Centers
• Others

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9399

Region :

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• MEA

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs